Julia Tigges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Tigges has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Ellen Fritsche
Leibniz Research Institute for Environmental Medicine (IUF), Düsseldorf, Germany
6 shared publicationsJean Krutmann
Leibniz Research Institute for Environmental Medicine (IUF), Düsseldorf, Germany
6 shared publications- Ellen Fritsche
IUF - Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany; DNTOX GmbH, Duesseldorf, Germany; Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany; SCAHT - Swiss Centre for Applied Human Toxicology, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
5 shared publications Ulrike Hübenthal
IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany
5 shared publicationsChristine Götz
IUF–Leibniz Research Institute for Environmental Medicine, Heinrich-Heine-University, Düsseldorf, Germany
4 shared publicationsHans F Merk
Department of Dermatology and Allergology, University Clinic RWTH Aachen, Aachen, Germany
3 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by Elsevier in NeuroToxicology
- Vol. 114, 103434
Early-stage quality—late-stage confidence: Neural induction quality control as a key to reproducible MEA-based neurotoxicity assays
- 20 March 2026
- Published by Elsevier in NeuroToxicology
- Vol. 114, 103434
Open AccessEarly-stage quality—late-stage confidence: Neural induction quality control as a key to reproducible MEA-based neurotoxicity assays
- Open Access
- 15 June 2022
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 39 (1) , 319-343
Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
Adverse outcome pathways (AOPs) are organized sequences of key events (KEs) that are triggered by a xenobiotic-induced molecular initiating event (MIE) and summit in an adverse outcome (AO) relevant to human or ecological health. The AOP framework causally connects toxicological mechanistic information with apical endpoints for application in regulatory sciences. AOPs are very useful to link endophenotypic, cellular endpoints in vitro to adverse health effects in vivo. In the field of in vitro developmental neurotoxicity (DNT), such cellular endpoints can be assessed using the human “Neurosphere Assay,” which depicts different endophenotypes for a broad variety of neurodevelopmental KEs. Combining this model with large-scale transcriptomics, we evaluated DNT hazards of two selected Chinese herbal medicines (CHMs) Lei Gong Teng (LGT) and Tian Ma (TM), and provided further insight into their modes-of-action (MoA). LGT disrupted hNPC migration eliciting an exceptional migration endophenotype. Time-lapse microscopy and intervention studies indicated that LGT disturbs laminin-dependent cell adhesion. TM impaired oligodendrocyte differentiation in human but not rat NPCs and activated a gene expression network related to oxidative stress. The LGT results supported a previously published AOP on radial glia cell adhesion due to interference with integrin-laminin binding, while the results of TM exposure were incorporated into a novel putative, stressor-based AOP. This study demonstrates that the combination of phenotypic and transcriptomic analyses is a powerful tool to elucidate compounds’ MoA and incorporate the results into novel or existing AOPs for a better perception of the DNT hazard in a regulatory context. Graphical abstract
- 15 June 2022
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 39 (1) , 319-343
Open AccessApplication of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
Adverse outcome pathways (AOPs) are organized sequences of key events (KEs) that are triggered by a xenobiotic-induced molecular initiating event (MIE) and summit in an adverse outcome (AO) relevant to human or ecological health. The AOP framework causally connects toxicological mechanistic information with apical endpoints for application in regulatory sciences. AOPs are very useful to link endophenotypic, cellular endpoints in vitro to adverse health effects in vivo. In the field of in vitro developmental neurotoxicity (DNT), such cellular endpoints can be assessed using the human “Neurosphere Assay,” which depicts different endophenotypes for a broad variety of neurodevelopmental KEs. Combining this model with large-scale transcriptomics, we evaluated DNT hazards of two selected Chinese herbal medicines (CHMs) Lei Gong Teng (LGT) and Tian Ma (TM), and provided further insight into their modes-of-action (MoA). LGT disrupted hNPC migration eliciting an exceptional migration endophenotype. Time-lapse microscopy and intervention studies indicated that LGT disturbs laminin-dependent cell adhesion. TM impaired oligodendrocyte differentiation in human but not rat NPCs and activated a gene expression network related to oxidative stress. The LGT results supported a previously published AOP on radial glia cell adhesion due to interference with integrin-laminin binding, while the results of TM exposure were incorporated into a novel putative, stressor-based AOP. This study demonstrates that the combination of phenotypic and transcriptomic analyses is a powerful tool to elucidate compounds’ MoA and incorporate the results into novel or existing AOPs for a better perception of the DNT hazard in a regulatory context. Graphical abstract
- 30 September 2021
- Published by Walter de Gruyter GmbH in Neuroforum
- Vol. 27 (4) , 201-212
Environmental exposures impact the nervous system in a life stage-specific manner
Exposure to environmental pollutants like chemicals or air pollution is major health concern for the human population. Especially the nervous system is a sensitive target for environmental toxins with exposures leading to life stage-dependent neurotoxicity. Developmental and adult neurotoxicity are characterized by specific adverse outcomes ranging from neurodevelopmental disorders to neurodegenerative diseases like Alzheimer’s and Parkinson’s disease. The risk assessment process for human health protection is currently undergoing a paradigm change toward new approach methods that allow mechanism-based toxicity assessment. As a flagship project, an in vitro battery of test methods for developmental neurotoxicity evaluation is currently supported by the Organization for Economic Co-operation and Development (OECD). A plethora of stem cell-based methods including brain spheres and organoids are currently further developed to achieve time- and cost-saving tools for linking MoA-based hazards to adverse health effects observed in humans.
- 30 September 2021
- Published by Walter de Gruyter GmbH in Neuroforum
- Vol. 27 (4) , 201-212
Environmental exposures impact the nervous system in a life stage-specific manner
Exposure to environmental pollutants like chemicals or air pollution is major health concern for the human population. Especially the nervous system is a sensitive target for environmental toxins with exposures leading to life stage-dependent neurotoxicity. Developmental and adult neurotoxicity are characterized by specific adverse outcomes ranging from neurodevelopmental disorders to neurodegenerative diseases like Alzheimer’s and Parkinson’s disease. The risk assessment process for human health protection is currently undergoing a paradigm change toward new approach methods that allow mechanism-based toxicity assessment. As a flagship project, an in vitro battery of test methods for developmental neurotoxicity evaluation is currently supported by the Organization for Economic Co-operation and Development (OECD). A plethora of stem cell-based methods including brain spheres and organoids are currently further developed to achieve time- and cost-saving tools for linking MoA-based hazards to adverse health effects observed in humans.
- Open Access
Stem Cells for Next Level Toxicity Testing in the 21st Century
The call for a paradigm change in toxicology from the United States National Research Council in 2007 initiates awareness for the invention and use of human‐relevant alternative methods for toxicological hazard assessment. Simple 2D in vitro systems may serve as first screening tools, however, recent developments infer the need for more complex, multicellular organotypic models, which are superior in mimicking the complexity of human organs. In this review article most critical organs for toxicity assessment, i.e., skin, brain, thyroid system, lung, heart, liver, kidney, and intestine are discussed with regards to their functions in health and disease. Embracing the manifold modes‐of‐action how xenobiotic compounds can interfere with physiological organ functions and cause toxicity, the need for translation of such multifaceted organ features into the dish seems obvious. Currently used in vitro methods for toxicological applications and ongoing developments not yet arrived in toxicity testing are discussed, especially highlighting the potential of models based on embryonic stem cells and induced pluripotent stem cells of human origin. Finally, the application of innovative technologies like organs‐on‐a‐chip and genome editing point toward a toxicological paradigm change moves into action.
Open AccessStem Cells for Next Level Toxicity Testing in the 21st Century
The call for a paradigm change in toxicology from the United States National Research Council in 2007 initiates awareness for the invention and use of human‐relevant alternative methods for toxicological hazard assessment. Simple 2D in vitro systems may serve as first screening tools, however, recent developments infer the need for more complex, multicellular organotypic models, which are superior in mimicking the complexity of human organs. In this review article most critical organs for toxicity assessment, i.e., skin, brain, thyroid system, lung, heart, liver, kidney, and intestine are discussed with regards to their functions in health and disease. Embracing the manifold modes‐of‐action how xenobiotic compounds can interfere with physiological organ functions and cause toxicity, the need for translation of such multifaceted organ features into the dish seems obvious. Currently used in vitro methods for toxicological applications and ongoing developments not yet arrived in toxicity testing are discussed, especially highlighting the potential of models based on embryonic stem cells and induced pluripotent stem cells of human origin. Finally, the application of innovative technologies like organs‐on‐a‐chip and genome editing point toward a toxicological paradigm change moves into action.
- 1 September 2014
- Published by Elsevier in Toxicology Letters
- Vol. 229, S148-S149
The aryl hydrocarbon receptor (AHR) is a new target for prevention and treatment of cutaneous squamous cell carcinomas
- 1 September 2014
- Published by Elsevier in Toxicology Letters
- Vol. 229, S148-S149
The aryl hydrocarbon receptor (AHR) is a new target for prevention and treatment of cutaneous squamous cell carcinomas
- 1 August 2014
- Published by Elsevier in Experimental Gerontology
- Vol. 56, 59-68
Inadequate mito-biogenesis in primary dermal fibroblasts from old humans is associated with impairment of PGC1A-independent stimulation
- 1 August 2014
- Published by Elsevier in Experimental Gerontology
- Vol. 56, 59-68
Inadequate mito-biogenesis in primary dermal fibroblasts from old humans is associated with impairment of PGC1A-independent stimulation
- Open Access
- 1 February 2014
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (2) , 556-559
The New Aryl Hydrocarbon Receptor Antagonist E/Z-2-Benzylindene-5,6-Dimethoxy-3,3-Dimethylindan-1-One Protects against UVB-Induced Signal Transduction
- 1 February 2014
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (2) , 556-559
Open AccessThe New Aryl Hydrocarbon Receptor Antagonist E/Z-2-Benzylindene-5,6-Dimethoxy-3,3-Dimethylindan-1-One Protects against UVB-Induced Signal Transduction
- 1 January 2013
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (1) , 87-96
Aryl Hydrocarbon Receptor Repressor (AhRR) Function Revisited: Repression of CYP1 Activity in Human Skin Fibroblasts Is Not Related to AhRR Expression
- 1 January 2013
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (1) , 87-96
Aryl Hydrocarbon Receptor Repressor (AhRR) Function Revisited: Repression of CYP1 Activity in Human Skin Fibroblasts Is Not Related to AhRR Expression
- Open Access
- 1 June 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (24) , 20056-20069
Estradiol Protects Dermal Hyaluronan/Versican Matrix during Photoaging by Release of Epidermal Growth Factor from Keratinocytes
- 1 June 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (24) , 20056-20069
Open AccessEstradiol Protects Dermal Hyaluronan/Versican Matrix during Photoaging by Release of Epidermal Growth Factor from Keratinocytes
- Open Access
- 12 March 2012
- Published by Wiley in Experimental Dermatology
- Vol. 21 (5) , 358-363
Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte‐based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I)
Abstract: Skin is important for the absorption and metabolism of exposed chemicals such as cosmetics or pharmaceuticals. The Seventh Amendment to the EU Cosmetics Directive prohibits the use of animals for cosmetic testing for certain endpoints, such as genotoxicity; therefore, there is an urgent need to understand the xenobiotic metabolizing capacities of human skin and to compare these activities with reconstructed 3D skin models developed to replace animal testing. We have measured Phase I enzyme activities of cytochrome P450 (CYP) and cyclooxygenase (COX) in ex vivo human skin, the 3D skin model EpiDerm™ (EPI‐200), immortalized keratinocyte‐based cell lines and primary normal human epidermal keratinocytes. Our data demonstrate that basal CYP enzyme activities are very low in whole human skin and EPI‐200 as well as keratinocytes. In addition, activities in monolayer cells differed from organotypic tissues after induction. COX activity was similar in skin, EPI‐200 and NHEK cells, but was significantly lower in immortalized keratinocytes. Hence, the 3D model EPI‐200 might represent a more suitable model for dermatotoxicological studies. Altogether, these data help to better understand skin metabolism and expand the knowledge of in vitro alternatives used for dermatotoxicity testing.
- 12 March 2012
- Published by Wiley in Experimental Dermatology
- Vol. 21 (5) , 358-363
Open AccessXenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte‐based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I)
Abstract: Skin is important for the absorption and metabolism of exposed chemicals such as cosmetics or pharmaceuticals. The Seventh Amendment to the EU Cosmetics Directive prohibits the use of animals for cosmetic testing for certain endpoints, such as genotoxicity; therefore, there is an urgent need to understand the xenobiotic metabolizing capacities of human skin and to compare these activities with reconstructed 3D skin models developed to replace animal testing. We have measured Phase I enzyme activities of cytochrome P450 (CYP) and cyclooxygenase (COX) in ex vivo human skin, the 3D skin model EpiDerm™ (EPI‐200), immortalized keratinocyte‐based cell lines and primary normal human epidermal keratinocytes. Our data demonstrate that basal CYP enzyme activities are very low in whole human skin and EPI‐200 as well as keratinocytes. In addition, activities in monolayer cells differed from organotypic tissues after induction. COX activity was similar in skin, EPI‐200 and NHEK cells, but was significantly lower in immortalized keratinocytes. Hence, the 3D model EPI‐200 might represent a more suitable model for dermatotoxicological studies. Altogether, these data help to better understand skin metabolism and expand the knowledge of in vitro alternatives used for dermatotoxicity testing.